ARKW vs IBB
ARK Next Generation Internet ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.76% for ARKW.
- • ARKW pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | ARKW | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.76% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.60% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $1.68B | $11.50B |
YTD return | -2.91% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.36 | 0.60 |
P/E ratio | 32.79 | 25.48 |
Last price | $147.14 | $217.75 |
Inception | — | — |
Issuer | ARK | iShares |
ARKW top holdings
| TSLA | Tesla Inc | 8.49% |
| META | Meta Platforms Inc Class A | 5.12% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.54% |
| AMZN | Amazon.com Inc | 4.42% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.38% |
| NVDA | NVIDIA Corp | 4.19% |
| HOOD | Robinhood Markets Inc Class A | 3.73% |
| CRWV | CoreWeave Inc Ordinary Shares - Class A | 3.68% |
| SPCX | Space Exploration Technologies Corp Class A | 3.68% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About ARKW
ARKW (ARK Next Generation Internet ETF) is Active strategy targeting next-gen internet companies. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.76%, a dividend yield of 1.60%. Its largest holding is Tesla Inc (TSLA), which represents 8.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 17.4%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.